TY - JOUR
T1 - Potential donor characteristics and decisions made by organ procurement organization staff
T2 - Results of a discrete choice experiment
AU - Predmore, Zachary
AU - Doby, Brianna
AU - Durand, Christine M.
AU - Segev, Dorry L.
AU - Sugarman, Jeremy
AU - Tobian, Aaron A.R.
AU - Wu, Albert W.
N1 - Funding Information:
This work was supported in part by the National Institute of Allergy and Infectious Diseases, grant numbers been 1R01AI120938 (Aaron A.R. Tobian), U01AI138897 (Christine M. Durand/ Dorry Segev), and U01AI134591 (Christine M. Durand/ Dorry Segev). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.
Funding Information:
This work was supported in part by the National Institute of Allergy and Infectious Diseases, grant numbers been 1R01AI120938 (Aaron A.R. Tobian), U01AI138897 (Christine M. Durand/ Dorry Segev), and U01AI134591 (Christine M. Durand/ Dorry Segev). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.
Publisher Copyright:
© 2021 Wiley Periodicals LLC
PY - 2021/10
Y1 - 2021/10
N2 - Organ procurement organizations (OPOs) evaluate referrals for deceased organ donation in the United States. Efforts to expand the donor pool, such as the HIV organ policy equity (HOPE) Act that permits transplants from HIV-positive donors to HIV-positive recipients, can only succeed if OPOs pursue referrals. However, relatively little is known about how OPO staff evaluate referrals. To better understand this process, OPO staff completed a discrete choice experiment to quantify the relative importance of seven donor characteristics on the decision to pursue a theoretical donor. Relative importance was defined by Partworth utility using a hierarchical Bayesian conditional logit model. There were 51 respondents from 36 of 58 OPOs in the United States. Of the seven attributes, organ and tissue potential were the most influential, followed by age, type of death, HIV status, donor registration, and Hepatitis C status. To be preferred to an HIV-negative donor, an HIV-positive donor needed to have the potential to donate two additional organs. These data provide insight into the preferences of OPO referral staff and may help explain the lower than expected number of HIV-positive transplants performed since the passage of the HOPE Act.
AB - Organ procurement organizations (OPOs) evaluate referrals for deceased organ donation in the United States. Efforts to expand the donor pool, such as the HIV organ policy equity (HOPE) Act that permits transplants from HIV-positive donors to HIV-positive recipients, can only succeed if OPOs pursue referrals. However, relatively little is known about how OPO staff evaluate referrals. To better understand this process, OPO staff completed a discrete choice experiment to quantify the relative importance of seven donor characteristics on the decision to pursue a theoretical donor. Relative importance was defined by Partworth utility using a hierarchical Bayesian conditional logit model. There were 51 respondents from 36 of 58 OPOs in the United States. Of the seven attributes, organ and tissue potential were the most influential, followed by age, type of death, HIV status, donor registration, and Hepatitis C status. To be preferred to an HIV-negative donor, an HIV-positive donor needed to have the potential to donate two additional organs. These data provide insight into the preferences of OPO referral staff and may help explain the lower than expected number of HIV-positive transplants performed since the passage of the HOPE Act.
KW - HIV
KW - HOPE Act
KW - discrete choice experiment
KW - organ procurement organization
UR - http://www.scopus.com/inward/record.url?scp=85114508690&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114508690&partnerID=8YFLogxK
U2 - 10.1111/tid.13721
DO - 10.1111/tid.13721
M3 - Article
C2 - 34463013
AN - SCOPUS:85114508690
SN - 1398-2273
VL - 23
JO - Transplant Infectious Disease
JF - Transplant Infectious Disease
IS - 5
M1 - e13721
ER -